167 related articles for article (PubMed ID: 29187546)
1. Pathogenesis, Humoral Immune Responses, and Transmission between Cohoused Animals in a Ferret Model of Human Respiratory Syncytial Virus Infection.
Chan KF; Carolan LA; Druce J; Chappell K; Watterson D; Young P; Korenkov D; Subbarao K; Barr IG; Laurie KL; Reading PC
J Virol; 2018 Feb; 92(4):. PubMed ID: 29187546
[TBL] [Abstract][Full Text] [Related]
2. Transmission of Human Respiratory Syncytial Virus in the Immunocompromised Ferret Model.
de Waal L; Smits SL; Veldhuis Kroeze EJB; van Amerongen G; Pohl MO; Osterhaus ADME; Stittelaar KJ
Viruses; 2018 Jan; 10(1):. PubMed ID: 29301313
[TBL] [Abstract][Full Text] [Related]
3. Animal models of respiratory syncytial virus infection.
Taylor G
Vaccine; 2017 Jan; 35(3):469-480. PubMed ID: 27908639
[TBL] [Abstract][Full Text] [Related]
4. Contribution of Fcγ receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells.
Gómez RS; Ramirez BA; Céspedes PF; Cautivo KM; Riquelme SA; Prado CE; González PA; Kalergis AM
Immunology; 2016 Jan; 147(1):55-72. PubMed ID: 26451966
[TBL] [Abstract][Full Text] [Related]
5. Human respiratory syncytial virus infection in the pre-clinical calf model.
Cortjens B; de Jong R; Bonsing JG; van Woensel JBM; Bem RA; Antonis AFG
Comp Immunol Microbiol Infect Dis; 2019 Aug; 65():213-218. PubMed ID: 31300116
[TBL] [Abstract][Full Text] [Related]
6. Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia-Implications for Vaccine Design.
Rey-Jurado E; Kalergis AM
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28273842
[TBL] [Abstract][Full Text] [Related]
7. The Secretome Profiling of a Pediatric Airway Epithelium Infected with hRSV Identified Aberrant Apical/Basolateral Trafficking and Novel Immune Modulating (CXCL6, CXCL16, CSF3) and Antiviral (CEACAM1) Proteins.
Touzelet O; Broadbent L; Armstrong SD; Aljabr W; Cloutman-Green E; Power UF; Hiscox JA
Mol Cell Proteomics; 2020 May; 19(5):793-807. PubMed ID: 32075873
[TBL] [Abstract][Full Text] [Related]
8. Cytokines in the Respiratory Airway as Biomarkers of Severity and Prognosis for Respiratory Syncytial Virus Infection: An Update.
Vázquez Y; González L; Noguera L; González PA; Riedel CA; Bertrand P; Bueno SM
Front Immunol; 2019; 10():1154. PubMed ID: 31214165
[TBL] [Abstract][Full Text] [Related]
9. Benzimidazole analogs inhibit respiratory syncytial virus G protein function.
Evans CW; Atkins C; Pathak A; Gilbert BE; Noah JW
Antiviral Res; 2015 Sep; 121():31-8. PubMed ID: 26116756
[TBL] [Abstract][Full Text] [Related]
10. A New Derivative of Retro-2 Displays Antiviral Activity against Respiratory Syncytial Virus.
Le Rouzic A; Fix J; Vinck R; Kappler-Gratias S; Volmer R; Gallardo F; Eléouët JF; Keck M; Cintrat JC; Barbier J; Gillet D; Galloux M
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203585
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Aerosol and Intranasal Exposure Models in Ferrets.
Zumbrun EE; Zak SE; Lee ED; Bowling PA; Ruiz SI; Zeng X; Koehler JW; Delp KL; Bakken RR; Hentschel SS; Bloomfield HA; Ricks KM; Clements TL; Babka AM; Dye JM; Herbert AS
Viruses; 2023 Nov; 15(12):. PubMed ID: 38140582
[TBL] [Abstract][Full Text] [Related]
12. Understanding the transmission dynamics of respiratory syncytial virus using multiple time series and nested models.
White LJ; Mandl JN; Gomes MG; Bodley-Tickell AT; Cane PA; Perez-Brena P; Aguilar JC; Siqueira MM; Portes SA; Straliotto SM; Waris M; Nokes DJ; Medley GF
Math Biosci; 2007 Sep; 209(1):222-39. PubMed ID: 17335858
[TBL] [Abstract][Full Text] [Related]
13. Ferrets are valuable models for SARS-CoV-2 research.
Ciurkiewicz M; Armando F; Schreiner T; de Buhr N; Pilchová V; Krupp-Buzimikic V; Gabriel G; von Köckritz-Blickwede M; Baumgärtner W; Schulz C; Gerhauser I
Vet Pathol; 2022 Jul; 59(4):661-672. PubMed ID: 35001763
[TBL] [Abstract][Full Text] [Related]
14. Intranasal Infection of Ferrets with SARS-CoV-2 as a Model for Asymptomatic Human Infection.
Everett HE; Lean FZX; Byrne AMP; van Diemen PM; Rhodes S; James J; Mollett B; Coward VJ; Skinner P; Warren CJ; Bewley KR; Watson S; Hurley S; Ryan KA; Hall Y; Simmons H; Núñez A; Carroll MW; Brown IH; Brookes SM
Viruses; 2021 Jan; 13(1):. PubMed ID: 33467732
[TBL] [Abstract][Full Text] [Related]
15. A Mixture of T-Cell Epitope Peptides Derived from Human Respiratory Syncytial Virus F Protein Conferred Protection in DR1-TCR Tg Mice.
Guo H; Song Y; Li H; Hu H; Shi Y; Jiang J; Guo J; Cao L; Mao N; Zhang Y
Vaccines (Basel); 2024 Jan; 12(1):. PubMed ID: 38250890
[TBL] [Abstract][Full Text] [Related]
16. The Intersection of Age and Influenza Severity: Utility of Ferrets for Dissecting the Age-Dependent Immune Responses and Relevance to Age-Specific Vaccine Development.
Rioux M; Francis ME; Swan CL; Ge A; Kroeker A; Kelvin AA
Viruses; 2021 Apr; 13(4):. PubMed ID: 33920917
[TBL] [Abstract][Full Text] [Related]
17. Two synthetic steroid analogs reduce human respiratory syncytial virus replication and the immune response to infection both
Bueno CA; Salinas FM; Vazquez L; Alché LE; Michelini FM
Heliyon; 2023 Oct; 9(10):e20148. PubMed ID: 37822633
[TBL] [Abstract][Full Text] [Related]
18. Preclinical animal models to evaluate therapeutic antiviral antibodies.
De Meyer A; Meuleman P
Antiviral Res; 2024 May; 225():105843. PubMed ID: 38548022
[TBL] [Abstract][Full Text] [Related]
19. A fluorescence polarization assay using an engineered human respiratory syncytial virus F protein as a direct screening platform.
Park M; Matsuura H; Lamb RA; Barron AE; Jardetzky TS
Anal Biochem; 2011 Feb; 409(2):195-201. PubMed ID: 20971054
[TBL] [Abstract][Full Text] [Related]
20. The Importance of miRNA Identification During Respiratory Viral Infections.
Martinez-Espinoza I; Banos-Lara MDR; Guerrero-Plata A
J Cell Immunol; 2021; 3(4):207-214. PubMed ID: 34541575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
